<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37352246</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Evaluation of renal markers in systemic autoimmune diseases.</ArticleTitle><Pagination><StartPage>e0278441</StartPage><MedlinePgn>e0278441</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0278441</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0278441</ELocationID><Abstract><AbstractText>Renal involvement is a common occurrence in subjects with systemic autoimmune diseases. The renal manifestation and its severity depend on the underlying condition and may reversely complicate the clinical course of autoimmune diseases. Renal function markers have been widely used in the assessment of normal functioning of kidneys including glomerular filtration rate and concentrating and diluting capacity of the kidney. An increase or decrease in the values of these markers may indicate kidney dysfunction. In this study, a number of critical renal markers were examined in seropositive autoimmune diseases including systemic lupus erythematosus (SLE), connective tissue disorder (CTD), and rheumatoid arthritis (RA). The data from three cohorts of subjects enrolled in renal markers and autoimmune antibody testing between January 2015 to August 2019 were retrospectively studied. The prevalence of renal markers that were out of the reference range and their average levels in female and male subgroups across SLE, CTD, and RA cohorts were compared and analyzed. The levels of renal markers are significantly affected by the presence of autoantibodies, in particular eGFR, cystatin C, and albumin. Autoantibodies were also more frequent in subjects with severe renal function damage. Close follow-up of both renal markers and autoantibodies may potentially assist in the early diagnosis of kidney diseases and improve the survival and life expectancy of autoimmune patients.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Krishnamurthy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krishnamurthy</LastName><ForeName>Hari</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7832-8423</Identifier><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishna</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayaraman</LastName><ForeName>Vasanth</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tianhao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bei</LastName><ForeName>Kang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajasekaran</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Vibrant America LLC., San Carlos, CA, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003240" MajorTopicYN="Y">Connective Tissue Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: YY and QS are paid employees of Vibrant America LLC. KK, VJ, TW, KB, HK, JJR, are paid employees of Vibrant Sciences LLC. Vibrant Sciences or Vibrant America could benefit from increased testing based on the results. There are no patents, products in development, or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37352246</ArticleId><ArticleId IdType="pmc">PMC10289317</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0278441</ArticleId><ArticleId IdType="pii">PONE-D-22-31509</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang L, Wang F&#x2010; S, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369&#x2013;395. doi: 10.1111/joim.12395</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12395</ArticleId><ArticleId IdType="pubmed">26212387</ArticleId></ArticleIdList></Reference><Reference><Citation>Suurmond J, Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest. 2015;125(6):2194&#x2013;2202. doi: 10.1172/JCI78084</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI78084</ArticleId><ArticleId IdType="pmc">PMC4497746</ArticleId><ArticleId IdType="pubmed">25938780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal T, Rathi M. Rheumatological diseases and kidneys: a nephrologist&#x2019;s perspective. Int J Rheum Dis. 2014;17:834&#x2013;844. doi: 10.1111/1756-185X.12424</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12424</ArticleId><ArticleId IdType="pubmed">24952962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Medicine. 2013;11:95 doi: 10.1186/1741-7015-11-95</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-95</ArticleId><ArticleId IdType="pmc">PMC3616816</ArticleId><ArticleId IdType="pubmed">23557013</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshan SV, Jennette JC. Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med. 2009;133:233&#x2013;248. doi: 10.5858/133.2.233</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/133.2.233</ArticleId><ArticleId IdType="pubmed">19195967</ArticleId></ArticleIdList></Reference><Reference><Citation>Penn H, Howie AJ, Kingdon EJ, et al.. Scleroderma renal crisis: patient characteristics and longterm outcomes. QJM. 2007;100:485&#x2013;494. doi: 10.1093/qjmed/hcm052</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcm052</ArticleId><ArticleId IdType="pubmed">17601770</ArticleId></ArticleIdList></Reference><Reference><Citation>Goules A, Masouridi S, Tzioufas AG, et al.. Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore). 2000;79:241&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">10941353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossini N, Savoldi S, Franceschini F, et al.. Clinical and morphological features of kidney involvement in primary Sjogren&#x2019;s syndrome. Nephrol Dial Transplant. 2001;16:2328&#x2013;2336.</Citation><ArticleIdList><ArticleId IdType="pubmed">11733624</ArticleId></ArticleIdList></Reference><Reference><Citation>Karie S, Gandjbakhch F, Janus N, et al.. Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology. 2008;47(3):350&#x2013;354. doi: 10.1093/rheumatology/kem370</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem370</ArticleId><ArticleId IdType="pubmed">18238787</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Callaghan CA. Renal manifestations of systemic autoimmune disease: diagnosis and therapy. Best Pract Res Clin Rheumatol. 2004;18(3):411&#x2013;427. doi: 10.1016/j.berh.2004.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.berh.2004.03.002</ArticleId><ArticleId IdType="pubmed">15158748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Bellomo R, Kellum J. Understanding renal functional reserve. Intensive Care Med. 2017;43: 917. doi: 10.1007/s00134-017-4691-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4691-6</ArticleId><ArticleId IdType="pubmed">28213622</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrinello G, Torres D, Testani JM, et al.. Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction. Intern Emerg Med. 2015;10:965. doi: 10.1007/s11739-015-1261-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-015-1261-1</ArticleId><ArticleId IdType="pubmed">26037394</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39:465&#x2013;490. doi: 10.1146/annurev.me.39.020188.002341</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.me.39.020188.002341</ArticleId><ArticleId IdType="pubmed">3285786</ArticleId></ArticleIdList></Reference><Reference><Citation>Glomerular Filtration Rate (GFR) Calculators. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/communication-programs/nkdep/laboratory-evaluation/glomerular-filtration-rate-calculators. Accessed on February 17, 2020.</Citation></Reference><Reference><Citation>Tidman M, Sj&#xf6;str&#xf6;m P, Jones I. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant. 2008;23(1):154&#x2013;160. doi: 10.1093/ndt/gfm661</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm661</ArticleId><ArticleId IdType="pubmed">17911090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang J, Katz R, Ix JH, et al.. Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders. Nephrol Dial Transplant. 2018;33(6):986&#x2013;992. doi: 10.1093/ndt/gfx229</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfx229</ArticleId><ArticleId IdType="pmc">PMC6251663</ArticleId><ArticleId IdType="pubmed">28992097</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhondup T, Qian Q. Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure. Blood Purif. 2017;43(1&#x2013;3):179&#x2013;188. doi: 10.1159/000452725</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000452725</ArticleId><ArticleId IdType="pubmed">28114143</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Krishna K, Ranganathan V, et al.. A multiplex autoantibody panel for early detection of autoimmune disease activity. Open J Rheumatol Autoimmune Dis. 2018;8:43&#x2013;52.</Citation></Reference><Reference><Citation>Kitridou RC, Akmal M, Turkel SB, et al.. Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study. Semin Arthritis Rheum. 1986;16:135&#x2013;145. doi: 10.1016/0049-0172(86)90047-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0049-0172(86)90047-8</ArticleId><ArticleId IdType="pubmed">3563525</ArticleId></ArticleIdList></Reference><Reference><Citation>Musa R., Brent L. H., &amp; Qurie A. (2022). Lupus Nephritis. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.</Citation><ArticleIdList><ArticleId IdType="pubmed">29762992</ArticleId></ArticleIdList></Reference><Reference><Citation>James S, Mitchel G. Physiology and disorder of water electrolytes and acid base metabolism. Tietz Textbook of clinical chemistry and molecular diagnostics. 4th ed. New Delhi: Elsevier; Inc; 2006. 1747&#x2013;1776.</Citation></Reference><Reference><Citation>Kidneys Gorenjak M. and Disease Autoimmune. EJIFCC. 2009;20(1):28&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975267</ArticleId><ArticleId IdType="pubmed">27683324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettritz R. Autoimmunity in kidney diseases. Scand J Clin Invest Suppl. 2008;241:99&#x2013;103. doi: 10.1080/00365510802150232</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365510802150232</ArticleId><ArticleId IdType="pubmed">18569975</ArticleId></ArticleIdList></Reference><Reference><Citation>Arad U, Balbir-Gurman A, Doenyas-Barak K, et al.. Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum. 2011;41:223&#x2013;229. doi: 10.1016/j.semarthrit.2010.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2010.11.001</ArticleId><ArticleId IdType="pubmed">21277620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>